Skip to main content
2026 CRT Conference Main banner

CRT 2026

Top Abstracts

Session:: Abstracts | Endovascular | Hypertension Therapies and Renal Denervation

Radiofrequency Renal Denervation Reduces Hypertensive Urgencies With Potential Healthcare Cost Savings In The United States: Two-year Pooled Analysis Of Randomized, Sham Controlled Trials

Saturday, March 7, 2026
2:42 PM - 2:48 PM EST
Location: Theater #4

    Speaker(s)

  • Raymond R. Townsend, MD

    Professor
    University of Pennsylvania, Pennsylvania, United States

    Disclosure(s): AstraZeneca: Consulting Fees (e.g., advisory boards) (Ongoing); BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing)